• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过协调多功能介孔硅纳米粒子的多种作用逆转异种移植模型中的癌症多药耐药性。

Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles.

机构信息

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University , Nanjing 210009, China.

出版信息

ACS Appl Mater Interfaces. 2016 Aug 31;8(34):22431-41. doi: 10.1021/acsami.6b04885. Epub 2016 Aug 16.

DOI:10.1021/acsami.6b04885
PMID:27420116
Abstract

A multistimuli responsive drug delivery system (DDS) based on sulfhydryl and amino-cofunctionalized mesoporous silica nanoparticles (SH/NH2-MSNs) has been developed, in which the multifunctional hyaluronic acid (HA) derivatives were grafted onto the SH/NH2-MSNs by disulfide bonds for targeting delivery, controlling drug release and reversing multidrug resistance (MDR). The doxorubicin (Dox) loaded multifunctional HA derivatives modified mesoporous silica nanoparticles (Dox/HHS-MSNs) were enzyme and redox sensitive, which could respond to the intracellular stimuli of hyaluronidase (HAase) and glutathione (GSH) successively and prevent drug leakage before reaching the tumor tissues. The cellular uptake experiments showed that Dox/HHS-MSNs were vulnerable to be endocytosed into the Dox-resistant human breast adenocarcinoma (MCF-7/ADR) cells, efficiently realized the endolysosomal escape and remained in the cytoplasm. Because of orchestrating multiple actions above including active targeting, endolysosomal escape and efficient multilevel drug release, Dox/HHS-MSNs could induce the strongest apoptosis and cytotoxicity of MCF-7/ADR cells. Furthermore, a series of in vivo studies on MCF-7/ADR tumor-bearing xenograft mouse models demonstrated that Dox/HHS-MSNs possessed the enhanced tumor-targeting capacity and the best therapeutic efficacy to reverse cancer MDR.

摘要

一种基于巯基和氨基共功能化介孔硅纳米粒子(SH/NH2-MSNs)的多刺激响应药物递送系统(DDS)已经被开发出来,其中多功能透明质酸(HA)衍生物通过二硫键接枝到 SH/NH2-MSNs 上,用于靶向递送、控制药物释放和逆转多药耐药(MDR)。负载多西紫杉醇(Dox)的多功能透明质酸衍生物修饰的介孔硅纳米粒子(Dox/HHS-MSNs)是酶和氧化还原敏感的,它可以分别响应细胞内透明质酸酶(HAase)和谷胱甘肽(GSH)的刺激,在到达肿瘤组织之前防止药物泄漏。细胞摄取实验表明,Dox/HHS-MSNs 很容易被内吞进入多西紫杉醇耐药的人乳腺癌腺癌细胞(MCF-7/ADR),有效地实现了内体逃逸并保留在细胞质中。由于协调了包括主动靶向、内体逃逸和高效多级药物释放在内的多种作用,Dox/HHS-MSNs 可以诱导 MCF-7/ADR 细胞最强的细胞凋亡和细胞毒性。此外,一系列在 MCF-7/ADR 荷瘤异种移植小鼠模型上的体内研究表明,Dox/HHS-MSNs 具有增强的肿瘤靶向能力和逆转癌症 MDR 的最佳治疗效果。

相似文献

1
Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles.通过协调多功能介孔硅纳米粒子的多种作用逆转异种移植模型中的癌症多药耐药性。
ACS Appl Mater Interfaces. 2016 Aug 31;8(34):22431-41. doi: 10.1021/acsami.6b04885. Epub 2016 Aug 16.
2
TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.TPGS 功能化介孔硅纳米粒子用于抗癌药物传递以克服多药耐药性。
Mater Sci Eng C Mater Biol Appl. 2018 Mar 1;84:108-117. doi: 10.1016/j.msec.2017.11.040. Epub 2017 Nov 28.
3
Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.用可被肿瘤脱落的透明质酸修饰的多功能介孔二氧化硅纳米颗粒作为阿霉素的载体
Colloids Surf B Biointerfaces. 2016 Aug 1;144:293-302. doi: 10.1016/j.colsurfb.2016.04.015. Epub 2016 Apr 8.
4
Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.多功能肽两亲嵌段介孔硅纳米粒子用于肿瘤靶向药物递送。
ACS Appl Mater Interfaces. 2017 Jan 25;9(3):2093-2103. doi: 10.1021/acsami.6b12647. Epub 2017 Jan 12.
5
Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism.载多柔比星介孔硅纳米粒逆转多药耐药:性能与机制。
Nanoscale. 2011 Oct 5;3(10):4314-22. doi: 10.1039/c1nr10580a. Epub 2011 Sep 5.
6
Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.用于刺激响应型药物释放和克服多药耐药性的混合脂质包覆的介孔硅。
ACS Appl Mater Interfaces. 2015 Feb 11;7(5):3342-51. doi: 10.1021/am5082793. Epub 2015 Jan 27.
7
Hyaluronic acid-modified mesoporous silica-coated superparamagnetic FeO nanoparticles for targeted drug delivery.透明质酸修饰的介孔硅包覆超顺磁性 FeO 纳米颗粒用于靶向药物递送。
Int J Nanomedicine. 2019 Jul 30;14:5785-5797. doi: 10.2147/IJN.S213974. eCollection 2019.
8
Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.基于多功能介孔硅纳米粒子的酶诱导和肿瘤靶向药物传递系统。
ACS Appl Mater Interfaces. 2015 May 6;7(17):9078-87. doi: 10.1021/acsami.5b00752. Epub 2015 Apr 24.
9
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.可还原交联透明质酸纳米粒用于主动靶向和智能递药系统对耐药 CD44+人乳腺癌肿瘤异种移植瘤的治疗。
J Control Release. 2015 May 10;205:144-54. doi: 10.1016/j.jconrel.2015.01.012. Epub 2015 Jan 14.
10
Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.用于靶向递送至CD44过表达癌细胞的双刺激响应性透明质酸共轭介孔二氧化硅
Acta Biomater. 2015 Sep;23:147-156. doi: 10.1016/j.actbio.2015.05.010. Epub 2015 May 15.

引用本文的文献

1
Complexed hyaluronic acid-based nanoparticles in cancer therapy and diagnosis: Research trends by natural language processing.基于复合透明质酸的纳米颗粒在癌症治疗与诊断中的应用:通过自然语言处理的研究趋势
Heliyon. 2024 Dec 18;11(1):e41246. doi: 10.1016/j.heliyon.2024.e41246. eCollection 2025 Jan 15.
2
Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.介孔硅纳米粒子的纳米结构原型用于创新的生物医学应用。
J Nanobiotechnology. 2022 Mar 12;20(1):126. doi: 10.1186/s12951-022-01315-x.
3
Cascade-Targeting of Charge-Reversal and Disulfide Bonds Shielding for Efficient DOX Delivery of Multistage Sensitive MSNs-COS-SS-CMC.
多级敏感 MSNs-COS-SS-CMC 的 DOX 递药的级联靶向电荷反转和二硫键屏蔽
Int J Nanomedicine. 2020 Aug 17;15:6153-6165. doi: 10.2147/IJN.S252769. eCollection 2020.
4
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.介孔硅纳米粒子在靶向刺激响应药物传递中的研究进展:最新研究。
Expert Opin Drug Deliv. 2019 Apr;16(4):415-439. doi: 10.1080/17425247.2019.1598375. Epub 2019 Apr 22.
5
Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance.丝胶纳米胶束增强了细胞摄取能力,并实现了阿霉素的 pH 触发释放,逆转了癌症耐药性。
Drug Deliv. 2018 Nov;25(1):1103-1116. doi: 10.1080/10717544.2018.1469686.
6
A nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance.一种基于纳米脂质体的光活化药物递送系统,用于增强癌症治疗和克服治疗抗性。
Int J Nanomedicine. 2017 Nov 14;12:8257-8275. doi: 10.2147/IJN.S143776. eCollection 2017.
7
Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery.紫杉醇和槲皮素纳米颗粒共载于微球中以延长肺部给药的保留时间。
Int J Nanomedicine. 2017 Nov 13;12:8239-8255. doi: 10.2147/IJN.S147028. eCollection 2017.
8
Sequential Delivery of Cyclopeptide RA-V and Doxorubicin for Combination Therapy on Resistant Tumor and Monitoring of Cytochrome c Release.环肽 RA-V 与多柔比星序贯给药用于耐药肿瘤联合治疗及细胞色素 c 释放监测。
Theranostics. 2017 Aug 23;7(15):3781-3793. doi: 10.7150/thno.20892. eCollection 2017.